Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,211
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 16,261–16,280 of 18,186 recalls

FDA Recall Terminated Historical recordClass II

Dermamedics Post Procedure Cream 1 oz. containers in the Dermamedics Post-Laser Treatment System with a SKU number of DM 1019

by Dermamedics, L.L.C.

Reason
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dermamedics Calm and Correct Serum, 2 oz. containers with a SKU number of BB10062 and 4 oz. containers with a SKU number of BB10068.

by Dermamedics, L.L.C.

Reason
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dermamedics Complexion Repair Topical Rehydrating Emulsion which was distributed in 50 ml containers with a SKU number of DM 1011 and Therametics Complexion Repair Topical Rehydrating Emulsion which was distributed in 50 ml containers with a SKU number of CR002.

by Dermamedics, L.L.C.

Reason
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dermamedics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SKU number of DM1016 and 0.25 containers with a SKU number of PS 1016; and Therametics Baby's Relief Calm and Repair Cream in 2 oz. containers with a SKU number of BR008.

by Dermamedics, L.L.C.

Reason
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dermamedics Calm & Correct Cream in 2 oz. containers with SKU number DM1020.

by Dermamedics, L.L.C.

Reason
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dermamedics Post Procedure Cream, 1 ounce containers which were distributed with a SKU number of DM 1026

by Dermamedics, L.L.C.

Reason
Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41.

by Boehringer Ingelheim Roxane Inc

Reason
Failed Stability Specifications: Out of specification result for preservative sodium benzoate.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30

by Pfizer Inc.

Reason
Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Aspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. By: McKesson Packaging Services a business unit of McKesson Corporation, concord, NC

by Mckesson Packaging Services

Reason
Failed Dissolution Specification; at the 12 month time interval.
Published
August 6, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

DENBLAN Anticavity Fluoride Toothpaste, Whitening formula, sodium monofluorophosphate 0.76%, 2.6 oz/75 mL tube, Laboratories Darphin, Dist, Paris France

by Estee Lauder Inc

Reason
Stability Data Does Not Support Expiry
Published
July 30, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Docusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Major Pharmaceuticals, Livonia, MI NDC 00904-5779-60

by Shamrock Medical Solutions Group LLC

Reason
Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg
Published
July 30, 2014
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass II

Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Amneal/Interpharm, NDC 53746-272-01

by Shamrock Medical Solutions Group LLC

Reason
Labeling: Label Mix up; product labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg instead of Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg
Published
July 30, 2014
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass II

Pramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfg: Northstar Rx, Memphis, TN NDC 16714-586-01

by Shamrock Medical Solutions Group LLC

Reason
Labeling: Label Mix up; product labeled to contain Nebivolol tablets actually contained Pramipexole Dihydrochloride tablets
Published
July 30, 2014
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass I

metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Amneal/Interpharm, Hauppauge, NY NDC 53746-178-01

by Shamrock Medical Solutions Group LLC

Reason
Labeling: Label Mix up; product labeled did not indicated Extended Release
Published
July 30, 2014
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass I

Oxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as Morphine Sulfate 20 mg/mL, Mfg: Lannett Co. Inc., Re-Packaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Cody Laboratories Inc., Cody, WY NDC 00527-1426-36

by Shamrock Medical Solutions Group LLC

Reason
Labeling: Label Mix up; product labeled as Morphine Sulfate 20 mg/mL actually contained OxyCODONE HCl 20 mg/mL
Published
July 30, 2014
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass I

Taztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: Shamrock Medical Solutions, Lewis Center, Ohio, Mfg: Watson Laboratories, Corona, CA NDC 62037-0696-90

by Shamrock Medical Solutions Group LLC

Reason
Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules
Published
July 30, 2014
Distribution
Product was shipped to the following sta…

View recall →

FDA Recall Terminated Historical recordClass III

Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.

by Sandoz Inc

Reason
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
Published
July 30, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Clonidine HCl Injection, 1000 mcg/10 mL (100 mcg/mL),10 mL Single Dose Vial, Rx only, Manufactured for: X-Gen Pharmaceuticals Inc., Big Flats, NY 14814, NDC 39822-2000-1.

by X-Gen Pharmaceuticals Inc.

Reason
Labeling: Label Error On Declared Strength: The side label description incorrectly states "Each mL contains 500 mcg Clonidine Hydrochloride" instead of stating "Each mL contains 100 mcg Clonidine Hydrochloride".
Published
July 30, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

VIRACEPT (R) (nelfinavir mesylate) Tablets, 625 mg, 120-count bottle, Rx only, Manufactured by: Agouron Pharmaceuticals, Inc. A Pfizer Company, Distributed by: ViV Healthcare Company, Research Triangle Park, NC 27709 NDC 63010-027-70

by Pfizer Inc.

Reason
Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016. The correct expiry date is 09/2016.
Published
July 23, 2014
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ChloraPrep With Tint, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), 26 mL APPLICATOR, Hi-Lite Orange. Rx Only. CareFusion, El Paso, TX 79912. NDC: 054365-400-13.

by CareFusion 213, LLC

Reason
Lack of Assurance of Sterility; Immediate product pouches may not be properly sealed.
Published
July 23, 2014
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.